Clinical utility of the Gen-Probe amplified Mycobacterium tuberculosis direct test compared with smear and culture for the diagnosis of pulmonary tuberculosis

Clinical Microbiology and Infection

Volumn 4, Issue 8, 1998, Pages 442-446

  Piersimoni, Claudio ^a   Zitti, Piergiorgio ^a   Cimarelli, Maria Enrica ^b   Nista, Domenico ^a   De Sio, Giuseppina ^a  

^a Azienda Ospedaliera Umberto I   (Italy)

^b General Hospital 'A Murri'   (Italy)

Author keywords

Diagnosis of partially treated patients; Direct detection; Pulmonary tuberculosis; rRNA amplification assay

Indexed keywords

RIBOSOME RNA;

ACID FAST BACTERIUM; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; GENE AMPLIFICATION; HUMAN; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SPUTUM SMEAR;

EID: 0031714821     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00392.x     Document Type: Article

References (23)

1. Hong Kong Chest Service/British Medical Research Council. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin and pyrazinamide. Results at 30 months. Am Rev Respir Dis 1991; 143: 700-6.
2. Sbarbaro JA, Catlin BJ, Iseman M. Long-term effectiveness of intermittent therapy for tuberculosis: final report of three Denver studies. Am Rev Respir Dis 1980; 121: 172-4.
3. Moore RD, Chaulk CP, Griffiths R, Cavalcante S, Chaisson RE. Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis. Am J Respir Crit Care Med 1996; 154: 1013-19.
4. Prevention and control of tuberculosis among homeless persons. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1992; 41(RR5): 13-23.
5. Centers for Disease Control and Prevention. Estimates of future global tuberculosis morbidity and mortality. MMWR 1993; 42: 961-4.
6. Pfaller MA. Application of new technology to the detection, identification and antimicrobial susceptibility testing of mycobacteria. Am J Clin Pathol 1994; 101: 329-37.
7. Heifets L. Mycobacteriology Laboratory. Clin Chest Med 1997; 18: 35-53.
8. Noordhoek GT, van Emden JDA, Kolk AHJ. Reliability of nucleic acid amplification for detection of M. tuberculosts an international collaborative quality control among 30 laboratories. J Clin Microbiol 1996; 34: 2522-5.
9. Bennedsen J, Ostergaard Thomsen V, Pfyffer GE, et al. Utility of PCR in diagnosing pulmonary tuberculosis. J Clin Microbiol 1996; 34: 1407-11.
10. Vlaspolder F, Singer P, Roggeveen C. Diagnostic value of an amplification method (Gen-Probe) compared with that of culture for diagnosis of tuberculosis. J Clin Microbiol 1995; 33: 2699-703.
11. Bradley SP, Reed SL, Catanzaro A. Clinical efficacy of the amplified M. tuberculosis direct test for the diagnosis of pulmonary tuberculosis. Am J Respir Crit Care Med 1996; 153: 1606-10.
12. Down JA, O'Connell MA, Dey MS, et al. Detection of M. tuberculosis in respiratory specimens by strand displacement amplification of DNA. J Clin Microbiol 1996; 34: 860-5.
13. Wobeser WL, Krajden M, Conly J, et al. Evaluation of Roche Amplicor PCR assay for M. tuberculosis. J Clin Microbiol 1996; 34: 134-9.
14. Nolte F, Metchock B. Identification of Mycobacteria. In: Murray PR, Baron EJO, Pfaller MA, et al, eds. Manual of clinical microbiology. Washington DC: American Society for Microbiology, 1995: 417-26.
15. Yajko DM, Wagner C, Tevere VJ, Kocagöz T, Handley WK, Chambers HF. Quantitative culture of M. tuberculosis from clinical sputum specimens and dilution endpoint of its detection by the Amplicor PCR. J Clin Microbiol 1995; 33: 1944-7.
16. American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990; 142: 725-35.
17. Pfyffer GE, Kissling P, Jahn EMI, Welscher HM, Salfinger M, Weber R. Diagnostic performance of amplified M. tuberculosis direct test with cerebrospinal fiuid, other non-respiratory and respiratory specimens. J Clin Microbiol 1996; 34: 834-41.
18. Yajko DM, Nassos PS, Sanders CA, Madej JJ, Hadley WK. High predictive value of the acid-fast smear for M. tuberculosis despite the high prevalence of Mycobacterium avium complex in respiratory specimens. Clin Infect Dis 1994; 19: 334-6.
19. Abe C, Hirano K, Wadw M, et al. Detection of M. tuberculosis in clinical specimens by polymerase chain reaction and Gen-Probe amplified M. tuberculosis direct test. J Clin Microbiol 1993; 31: 3270-4.
20. Pfyffer GE, Kissling P, Wirth R, Weber R. Direct detection of M. tuberculosis complex in respiratory specimens by a target-amplified test system. J Clin Microbiol 1994; 32: 918-23.
21. Miller N, Hernandez SG, Cleary TJ. Evaluation of Gen-Probe amplified M tuberculosis direct test and PCR for direct detection of M. tuberculosis in clinical specimens. J Clin Microbiol 1994; 32: 393-7.
22. Fairfax MR. Evaluation of the Gen-Probe amplified M. tuberculosis direct detection test. Am J Clin Pathol 1996; 106: 594-9.
23. Piersimoni C, Callegaro A, Nista D, et al. Comparative evaluation of two commercial amplification assays for direct detection of M. tuberculosis complex in respiratory specimens. J Clin Microbiol 1997, 35. 193-6.